Selected asthma characteristics of the hospital and Asthma Foundation cohorts
| Hospital (n=150) | Asthma Foundation (n=366) | |
|---|---|---|
| *Individuals who did not complete all of the questions relating to the determination of asthma severity were not classified into any of the asthma severity groups . †These values add up to more than 100% as many respondents were using more than one medication to treat their asthma. | ||
| Asthma severity* | ||
| Mild to moderate | 116 (77.3%) | 268 (73.2%) |
| Severe to very severe | 26 (17.3%) | 85 (23.2%) |
| Atopic | 74 (49.3%) | 135 (36.9%) |
| Nasal polyps | 25 (16.7%) | 59 (16.1%) |
| Exercise induced asthma | 113 (75.3%) | 283 (77.3%) |
| Seasonal asthma | 102 (68.0%) | 230 (62.8%) |
| Current asthma medications† | ||
| Short acting β2 agonists | 130 (86.7%) | 289 (79.0%) |
| Long acting β2 agonists | 47 (13.3%) | 53 (14.5%) |
| Inhaled corticosteroids | 137 (91.3%) | 278 (76.0%) |
| Sodium cromoglycate | 6 (4.0%) | 26 (7.1%) |
| Anticholinergics | 22 (14.7%) | 41 (11.2%) |
| Theophylline | 21 (14.0%) | 29 (7.9%) |
| Oral corticosteroids | 33 (22.0%) | 51 (13.9%) |